Back to
DRIEHAUS CAPITAL MANAGEMENT LLC
DRUG3 quarters
Position history for
DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in BRIGHT MINDS BIOSCIENCES INC
Yes. Driehaus Capital Management holds 433,377 shares of DRUG (Bright Minds Biosciences), worth $30.4M, as of its Q2 2026 13F filing. It increased the position by 862 shares (+0.2%) from Q1 2026. Driehaus Capital Management has held DRUG since Q4 2025, across 3 quarterly 13F filings. DRUG is 0.2% of Driehaus Capital Management's reported 13F portfolio.
Current Value
$30.4M
Current Shares
433,377
Total Value Change
+$9.4M
Total Shares Change
+163,736
Quarter-by-Quarter History
Other major holders of DRUG: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc.